Marlins trade Luzardo to Phillies for two prospects. Bendix reaction and fallout
The Marlins received outfielder Emaarion Boyd and shortstop Starlyn Caba, a 19-year-old who is rated as a top 100 MLB prospect by Baseball America (which has him 54th) and by MLB.com, which ranks him 81st.
Phillies boost rotation with Jesús Luzardo: Trade details, 2025 fantasy outlook
Philadelphia upgrades its starting rotation mix with southpaw Jesús Luzardo. How does the move impact top prospect Andrew Painter?
Marlins' Starlyn Caba: Traded for Luzardo
The Marlins acquired Caba and Emaarion Boyd from the Phillies on Sunday in exchange for left-hander Jesus Luzardo, Mark Feinsand of MLB.com reports.
Phillies, Marlins' Rotation, Payroll After Reported Jesús Luzardo, Starlyn Caba Trade
The Philadelphia Phillies have reportedly added to their already strong rotation. Per The Athletic's Matt Gelb, the Phillies traded 19-year-old
Jesús Luzardo bolsters Phillies rotation, Marlins add high-ceiling prospects: Law
The Phillies gave up talent but it is a trade every contender should make given Luzardo helps them now and the prospects are years away.
Phillies acquire left-hander Jesús Luzardo from Marlins in exchange for prospects
The Phillies acquired left-hander Jesús Luzardo from the Miami Marlins on Sunday, the team announced. Miami received two prospects, outfielder Emaarion Boyd and infielder Starlyn Caba. Philadelphia also acquired catcher Paul McIntosh in the trade.
Jesús Luzardo Traded to Phillies; Marlins Get Prospects Starlyn Caba, Emaarion Boyd
The Miami Marlins have traded left-handed starting pitcher Jesús Luzardo to the Philadelphia Phillies for two minor leaguers, shortstop Starlyn Caba
Phillies acquire lefty Jesús Luzardo in trade with Marlins
After an unsuccessful pursuit to make changes to their lineup, the Phillies are doubling down on their rotation. They have acquired lefty Jesús Luzardo from the Miami Marlins, the team announced Sunday. With Luzardo, the Phillies could form one of the best — if not the best — rotations in baseball next season.
Phillies acquire starting pitcher Jesus Luzardo from Marlins for prospects
The Philadelphia Phillies acquired left-handed starter Jesus Luzardo from the Miami Marlins on Sunday. The team also will receiver minor league catcher Paul McIntosh from the Marlins in exchange for shortstop Starlyn Caba and outfielder Emaarion Boyd.
Fantasy Baseball Today: Jesus Luzardo's move to the Phillies boosts upside plus first base updates
And it makes sense that so much of the league is looking for answers at that position because, as I pointed out in my State of the Position piece, first base is in a bad spot these days: "But first basemen aren't quite mashing like they used to,
Phillies Likely To Hold Onto $142 Million Star Following Jesús Luzardo Trade
The Philadelphia Phillies will likely hold onto trade candidate Alec Bohm following the recent Jesús Luzardo trade.
bovnews1d
Evercore ISI Reduced Rating for Cabaletta Bio Inc (CABA) Stock
Cabaletta Bio Inc (CABA) stock saw a decline, ending the day at $2.36 which represents a decrease of $-0.02 or -0.84% from the prior close of $2.38. The stock opened at $2.4 and touched a low of $2.25 ...
Hosted on MSN6d
Wells Fargo Downgrades Cabaletta Bio (CABA)
Fintel reports that on December 19, 2024, Wells Fargo downgraded their outlook for Cabaletta Bio (NasdaqGS:CABA) from ...
Cabaletta Bio (NASDAQ:CABA) Cut to “Inline” at Evercore ISI
Evercore ISI lowered shares of Cabaletta Bio (NASDAQ:CABA – Free Report) from an outperform rating to an inline rating in a research note published on Friday morning, MarketBeat.com reports. They ...
RotoBaller on MSN3d
Starlyn Caba Traded To Miami
According to Baseball America, the Miami Marlins are acquiring shortstop prospect Starlyn Caba from the Philadelphia Phillies in exchange for left-handed pitcher Jesus Luzardo. The Marlins have also ...
Yahoo Finance3d
Cabaletta Bio, Inc. (CABA)
PHILADELPHIA, Nov. 26, 2024 (GLOBE NEWSWIRE) -- Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology company focused on developing and launching the first curative targeted cell ...